IMVT - Immunovant GAAP EPS of -$0.36 beats by $0.07
2024-02-12 07:08:54 ET
More on Immunovant
- Immunovant: An Intriguing And Developing Story
- Chris DeMuth Sure Likes Uranium And SHF Holdings + 3 Litigation Ideas
- Immunovant stock jumps 9% on positive data for Graves' disease drug
- Immunovant gains after Phase 1 data for autoimmune therapy
- Seeking Alpha’s Quant Rating on Immunovant